OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Muhammad Bilal, Lobna El Tabei, Sören Büsker, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 12, pp. 1495-1508
Open Access | Times Cited: 22
Muhammad Bilal, Lobna El Tabei, Sören Büsker, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 12, pp. 1495-1508
Open Access | Times Cited: 22
Showing 22 citing articles:
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales
Rémy A. Bonnin, Cécile Emeraud, Agnès B. Jousset, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 8, pp. 1156.e1-1156.e5
Open Access | Times Cited: 59
Rémy A. Bonnin, Cécile Emeraud, Agnès B. Jousset, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 8, pp. 1156.e1-1156.e5
Open Access | Times Cited: 59
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
François Barbier, Sami Hraiech, Solen Kernéis, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
François Barbier, Sami Hraiech, Solen Kernéis, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
Davorka Repac Antić, Marijo Parčina, Ivana Gobin, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 28
Davorka Repac Antić, Marijo Parčina, Ivana Gobin, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 28
An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/avibactam, And Tobramycin Against Carbapenem-Resistant and -Susceptible Pseudomonas aeruginosa
Emel Mataracı Kara, Bekir Özer, Mesut Yılmaz, et al.
Microbial Pathogenesis (2025), pp. 107560-107560
Closed Access
Emel Mataracı Kara, Bekir Özer, Mesut Yılmaz, et al.
Microbial Pathogenesis (2025), pp. 107560-107560
Closed Access
Some evidence supporting the use of optically pure R-(−)-diniconazole: Toxicokinetics and configuration conversion on chiral diniconazole
Haoran Li, Kai Liu, Alan K. Chang, et al.
The Science of The Total Environment (2024) Vol. 937, pp. 173475-173475
Closed Access | Times Cited: 4
Haoran Li, Kai Liu, Alan K. Chang, et al.
The Science of The Total Environment (2024) Vol. 937, pp. 173475-173475
Closed Access | Times Cited: 4
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 4
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 4
Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects
Chuhan Zhang, Shu‐Yan Yu, Size Li, et al.
Advances in Therapy (2025)
Open Access
Chuhan Zhang, Shu‐Yan Yu, Size Li, et al.
Advances in Therapy (2025)
Open Access
Impact of continuous renal replacement therapy and Cytosorb on cefiderocol pharmacokinetics: “One size does not fit all”
Gabriella Bottari, G Isabella, Corrado Cecchetti, et al.
The International Journal of Artificial Organs (2025)
Closed Access
Gabriella Bottari, G Isabella, Corrado Cecchetti, et al.
The International Journal of Artificial Organs (2025)
Closed Access
Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers
Maria Sanz-Codina, Wisse van Os, Anh Duc Pham, et al.
Journal of Antimicrobial Chemotherapy (2024)
Open Access | Times Cited: 3
Maria Sanz-Codina, Wisse van Os, Anh Duc Pham, et al.
Journal of Antimicrobial Chemotherapy (2024)
Open Access | Times Cited: 3
The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
Dario Cattaneo, Cristina Gervasoni, Alberto Corona
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1410-1410
Open Access | Times Cited: 13
Dario Cattaneo, Cristina Gervasoni, Alberto Corona
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1410-1410
Open Access | Times Cited: 13
Alternative iron-depleted media for cefiderocol susceptibility testing
Brianna M. Eales, James E. Smith, Nazanin Pouya, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107193-107193
Closed Access | Times Cited: 2
Brianna M. Eales, James E. Smith, Nazanin Pouya, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107193-107193
Closed Access | Times Cited: 2
Toxicokinetics and bioavailability of indoxacarb enantiomers and their new metabolites in rats
Jiao Ai, Jianxin Li, Alan K. Chang, et al.
Pesticide Biochemistry and Physiology (2024) Vol. 203, pp. 106024-106024
Closed Access | Times Cited: 2
Jiao Ai, Jianxin Li, Alan K. Chang, et al.
Pesticide Biochemistry and Physiology (2024) Vol. 203, pp. 106024-106024
Closed Access | Times Cited: 2
Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
Carolin Prinz, Frank Streit, Christian Schumann, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 307-314
Open Access | Times Cited: 5
Carolin Prinz, Frank Streit, Christian Schumann, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 307-314
Open Access | Times Cited: 5
Treatment with cefiderocol in K. pneumoniae KPC nosocomial external ventricular drainage meningitis: A brief report
Francesco Colombo, Waheed Ali, Sandro Panese, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 8
Francesco Colombo, Waheed Ali, Sandro Panese, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 8
Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach
Helena Barrasa, Miguel Ángel Morán Rodríguez, Leire Fernández-Ciriza, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 553-553
Open Access | Times Cited: 1
Helena Barrasa, Miguel Ángel Morán Rodríguez, Leire Fernández-Ciriza, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 553-553
Open Access | Times Cited: 1
Pharmacokinetics of cefiderocol in a patient with carbapenem‐resistant Acinetobacter baumannii ventriculitis: A case report
Natalie A. Finch, Alejandro Granillo, Nazanin Pouya, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024)
Closed Access | Times Cited: 1
Natalie A. Finch, Alejandro Granillo, Nazanin Pouya, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024)
Closed Access | Times Cited: 1
Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration
Julia E. Möhlmann, Matthijs van Luin, Esther V. Uijtendaal, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 12, pp. 3753-3757
Open Access | Times Cited: 3
Julia E. Möhlmann, Matthijs van Luin, Esther V. Uijtendaal, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 12, pp. 3753-3757
Open Access | Times Cited: 3
Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis
Elisa Funiciello, Jacopo Mula, F Mignone, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 11, pp. 2776-2778
Closed Access | Times Cited: 2
Elisa Funiciello, Jacopo Mula, F Mignone, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 11, pp. 2776-2778
Closed Access | Times Cited: 2
Optimizing Cefiderocol Dosing Through Population Pharmacokinetic/Pharmacodynamic Simulation: An Assessment of Drug Cost Reductions
Kazutaka Oda, Hirofumi Jono, Hideyuki Saito
Therapeutic Drug Monitoring (2024)
Closed Access
Kazutaka Oda, Hirofumi Jono, Hideyuki Saito
Therapeutic Drug Monitoring (2024)
Closed Access
Cefiderocol (CFDC): A Spy Antibiotic Future Replacement of Carbapenem
Md. Rezwan Ahmed Mahedi, Kamilia Mounich, Chou‐Yi Hsu, et al.
Research Journal of Pharmacy and Technology (2023), pp. 5492-5496
Closed Access | Times Cited: 1
Md. Rezwan Ahmed Mahedi, Kamilia Mounich, Chou‐Yi Hsu, et al.
Research Journal of Pharmacy and Technology (2023), pp. 5492-5496
Closed Access | Times Cited: 1
A Drug Monograph; Cefiderocol
Betül Kars, Sevil Öztaş, Mustafa Altındiş
JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH (2023) Vol. 7, Iss. 1, pp. 9-25
Open Access
Betül Kars, Sevil Öztaş, Mustafa Altındiş
JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH (2023) Vol. 7, Iss. 1, pp. 9-25
Open Access
The solution to drug resistance of Gram-negative bacteria – Cefiderocol
Magdalena Kołodziej, Kamila Gorczyca, Ilona Jastrzębska, et al.
Journal of Education Health and Sport (2023) Vol. 33, Iss. 1, pp. 17-21
Open Access
Magdalena Kołodziej, Kamila Gorczyca, Ilona Jastrzębska, et al.
Journal of Education Health and Sport (2023) Vol. 33, Iss. 1, pp. 17-21
Open Access
